SCLC, EXTENSIVE STAGE
Clinical trials for SCLC, EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SCLC, EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial launches for Off-the-Shelf cell therapy against tough cancers
Disease control Not yet recruitingThis early-phase study tests a new cell therapy called NEUK203-13 in up to 9 people with advanced small cell lung cancer or neuroendocrine tumors that have stopped responding to standard treatments. The therapy uses specially engineered immune cells (CAR-NK) made from stem cells,…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 17, 2026 04:30 UTC
-
New combo therapy aims to slow aggressive lung cancer
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer who have not had treatment before. The approach combines the drug bemotuzumab with standard chemotherapy and anlotinib, followed by chest radiation. The goal is to see if this combination can …
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 17, 2026 04:29 UTC
-
New hope for tough lung cancer: experimental drug IBI363 targets tumors after immunotherapy fails
Disease control Not yet recruitingThis study tests an experimental drug called IBI363 in 35 people with advanced small cell lung cancer that has worsened after at least two prior treatments, including immunotherapy. The goal is to see if IBI363 can shrink tumors or slow the disease. Participants will receive the …
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
New hope for aggressive lung cancer: Real-World study of toripalimab launches
Disease control Not yet recruitingThis study looks at how well the drug Toripalimab works for people with extensive-stage small cell lung cancer, a fast-growing cancer. Researchers will track about 1,200 patients in China to see how long they live without the cancer getting worse and how safe the treatment is. Th…
Matched conditions: SCLC, EXTENSIVE STAGE
Sponsor: Fudan University • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New cocktail therapy aims to shrink tough lung cancers
Disease control Not yet recruitingThis study tests a new treatment plan for people with extensive-stage small cell lung cancer (ES-SCLC) who have not had prior therapy. Participants receive a combination of benmelstobart (an immunotherapy), anlotinib (a targeted drug), and chemotherapy, followed by chest radiatio…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Can a cancer drug keep working after it fails? new study investigates
Knowledge-focused Not yet recruitingThis study looks at whether the drug anlotinib can still help people with advanced lung cancer even after it has stopped working. Researchers will review medical records from 350 patients with non-small cell or small cell lung cancer. The goal is to see if continuing anlotinib in…
Matched conditions: SCLC, EXTENSIVE STAGE
Sponsor: Henan Cancer Hospital • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC